<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="506">
  <stage>Registered</stage>
  <submitdate>11/09/2005</submitdate>
  <approvaldate>28/09/2005</approvaldate>
  <actrnumber>ACTRN12605000533695</actrnumber>
  <trial_identification>
    <studytitle>Randomized controlled trial of antibiotics in children with chronic moist cough</studytitle>
    <scientifictitle>A randomized double-blinded placebo-controlled trial of amoxycillin/clavulanic acid in children with chronic moist cough to improve cough scores.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic (&gt;3 weeks) moist cough in children</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention is 14 days of oral amoxycillin/clavulanate 400mg/5ml suspension.</interventions>
    <comparator>Placebo suspension at dose of 22.5mg/kg twice daily.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Success of treatment through the use of verbal category descriptive scores of cough, a previously validated tool.</outcome>
      <timepoint>Immediately pre-treatment and at the conclusion of treatment.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Bronchoalveolar lavage results will be available from day 1 in a percentage of patients and secondary outcomes will include the analysis of microbiology, cytology and inflammatory markers as evidence of a bacterial infection in responders and non-responders (all at day 1).
</outcome>
      <timepoint>Day 1 on enrolment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria> Children with chronic (&gt;3 week duration) moist cough.</inclusivecriteria>
    <inclusiveminage>6</inclusiveminage>
    <inclusiveminagetype>Months</inclusiveminagetype>
    <inclusivemaxage>14</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Clinical or HRCT-proven bronchiectasis, gross neurodevelopmental delay, cystic fibrosis, known chronic disease such as interstitial lung disease or cardiac disease. Also children who have had antibiotic therapy in the preceding 2 weeks or who are allergic to penicillin will be excluded.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>To ensure adequate concealment a black sticker obscures the next treatment group on the original treatment allocation sheet and a photocopy of this is used by the investigators. The original sheet with black stickers is held in the pharmacy department where the dipsensing of the mediciation is done without knowledge of investigators or patients.</concealment>
    <sequence>After written consent is obtained the children will be randomized, stratified by age ( &lt; 6 years and &gt;= 6 years of age). They will subsequently be allocated to the next patient number on a list, which has been previously generated, in random order, by drawing a letter (a,b) from a container, at a remote site by a non-investigator.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/01/2004</anticipatedstartdate>
    <actualstartdate>5/01/2004</actualstartdate>
    <anticipatedenddate>1/12/2006</anticipatedenddate>
    <actualenddate>12/12/2006</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>50</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Department of Respiratory Medicine, Royal Children's Hospital</primarysponsorname>
    <primarysponsoraddress>Royal Children's Hospital, Herston Road, Herston, Qld, 4029</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>TSANZ/Allen and Hanbury's Paediatric Respiratory Medicine Career Development Fellowship</fundingname>
      <fundingaddress>C/- TSANZ GPO Box 1491, Sydney, NSW, 2001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Royal Children's Hospital Working Wonders Foundation</fundingname>
      <fundingaddress>Herston Road, Herston, Qld , 4029</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Julie Marchant</sponsorname>
      <sponsoraddress>Royal Children's Hospital, Respiratory Dept,
Level 5, Herston Road, Herston, Qld, 4029</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This trial aims to assess the efficacy of antibiotics in treating children with a prolonged wet cough.</summary>
    <trialwebsite />
    <publication>Marchant J, Masters IB, Champion A, Petsky H, Chang AB. Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough. Thorax. 2012 Aug; 67(8): 689-93</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Children's Hospital Ethics Committee</ethicname>
      <ethicaddress>Herston, Queensland</ethicaddress>
      <ethicapprovaldate>1/11/2003</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Julie Marchant</name>
      <address>Department of Respiratory Medicine
Royal Children's Hospital
Level 3
Woolworths Building
Herston Road
Herston QLD 4029</address>
      <phone>+61 7 36368523</phone>
      <fax>+61 7 36361958</fax>
      <email>j.marchant@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Julie Marchant</name>
      <address>Department of Respiratory Medicine
Royal Children's Hospital
Level 3
Woolworths Building
Herston Road
Herston QLD 4029</address>
      <phone>+61 7 36368523</phone>
      <fax>+61 7 36361958</fax>
      <email>j.marchant@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>as above</name>
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Julie Marchant</name>
      <address>Dr Julie Marchant
Level 7
Centre for Children's Health Research
64 Raymond Terrace
South Brisbane Qld 4101</address>
      <phone>+61730697350</phone>
      <fax />
      <email>j.marchant@uq.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>